Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stress-related mucosal damage.

D A Peura

    Clinical Therapeutics
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Stress-related mucosal damage (SRMD) in critically ill patients is a growing concern. Histamine H2-receptor antagonists like cimetidine are effective in preventing and treating SRMD, potentially through mechanisms beyond acid suppression.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Distinguishing the impact of dexlansoprazole on heartburn vs. regurgitation in patients with gastro-oesophageal reflux disease.

    Alimentary pharmacology & therapeutics·2013
    Same author

    The effects of increasing body mass index on heartburn severity, frequency and response to treatment with dexlansoprazole or lansoprazole.

    Alimentary pharmacology & therapeutics·2013
    Same author

    Risk factors associated with a decrease ≥2 g/dL in haemoglobin and/or ≥10% haematocrit in osteoarthritis patients taking celecoxib or a nonselective NSAID plus a PPI in a large randomised controlled trial (CONDOR).

    Alimentary pharmacology & therapeutics·2012
    Same author

    The 12-month safety profile of dexlansoprazole, a proton pump inhibitor with a dual delayed release formulation, in patients with gastro-oesophageal reflux disease.

    Alimentary pharmacology & therapeutics·2010
    Same author

    Changes of gastric histology in patients with erosive oesophagitis receiving long-term lansoprazole maintenance therapy.

    Alimentary pharmacology & therapeutics·2010
    Same author

    Safety profile of dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed release formulation: global clinical trial experience.

    Alimentary pharmacology & therapeutics·2009
    Same journal

    Early Feasibility Studies in Europe: A Multisite Qualitative Study of Operational Challenges and Site Selection Determinants at 6 University Hospitals.

    Clinical therapeutics·2026
    Same journal

    Safety of Celecoxib in Elderly Patients With Osteoarthritis: A Real-World Analysis Based on the FAERS Database.

    Clinical therapeutics·2026
    Same journal

    Reimagining Representation Across the Clinical Research Ecosystem: Part II of a Specialty Update on Advancing Diversity, Racial Equity, and Inclusion in Clinical Research.

    Clinical therapeutics·2026
    Same journal

    Combined Effects of Nicorandil and Enhanced External Counterpulsation on Coronary Microcirculation and Exercise Capacity in Patients With Coronary Slow Flow Phenomenon: A Randomized, Controlled, 3-Arm Trial.

    Clinical therapeutics·2026
    Same journal

    Phase 1 Study Evaluating Gefurulimab Pharmacokinetics and Safety Following Delivery Via Autoinjector or Prefilled Syringe With Needle Safety Device in Healthy Adults.

    Clinical therapeutics·2026
    Same journal

    Evaluating Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Associated With Newer Antiseizure Medications Using FAERS and JADER Combined With Bioinformatics Exploration.

    Clinical therapeutics·2026
    See all related articles

    Area of Science:

    • Gastroenterology
    • Critical Care Medicine
    • Pharmacology

    Background:

    • Stress-related mucosal damage (SRMD) is increasingly identified in critically ill patients.
    • The exact pathogenesis of SRMD remains unclear, but gastric acid is essential for its development.
    • Maintaining gastric mucosal barrier integrity is crucial for preventing SRMD.

    Purpose of the Study:

    • To review the therapeutic strategies for SRMD, focusing on acid suppression and mucosal defense.
    • To evaluate the efficacy of histamine H2-receptor antagonists (H2 blockers) and other agents in SRMD management.
    • To explore potential mechanisms of action for H2 blockers beyond acid inhibition.

    Main Methods:

    • Review of controlled studies and clinical trials on SRMD treatment.

    Related Experiment Videos

  • Analysis of the efficacy of histamine H2-receptor antagonists (e.g., cimetidine) compared to placebo and antacids.
  • Examination of the protective effects of sucralfate and exogenous prostaglandins on gastric mucosa.

    • Main Results:

    • Cimetidine has been confirmed as effective therapy for SRMD, outperforming placebo and matching antacids.
    • Histamine H2-receptor antagonists are effective for both prevention and treatment of SRMD.
    • Evidence suggests H2 blockers may possess antisecretory-independent mechanisms in treating SRMD.

    Conclusions:

    • Histamine H2-receptor antagonists are a valuable therapeutic option for SRMD in critically ill patients.
    • While acid reduction is key, H2 blockers might offer additional protective benefits.
    • Further research is needed to fully elucidate the mechanisms of SRMD and the non-antisecretory effects of H2 blockers.